GWM
ORCL icon

Geneos Wealth Management’s Oracle ORCL Stock Holding History

Geneos Wealth Management’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.27M Sell
22,197
-117
-0.5% -$19K 0.08% 278
2025
Q4 		$4.35M Buy
22,314
+982
+5% +$234K 0.11% 232
2025
Q3 		$6M Sell
21,332
-7,738
-27% -$1.97M 0.15% 169
2025
Q2 		$6.36M Sell
29,070
-22,636
-44% -$3.66M 0.16% 162
2025
Q1 		$7.23M Buy
51,706
+30,354
+142% +$4.94M 0.1% 241
2024
Q4 		$3.56M Buy
21,352
+765
+4% +$136K 0.12% 190
2024
Q3 		$3.51M Buy
20,587
+3,920
+24% +$568K 0.13% 185
2024
Q2 		$2.35M Sell
16,667
-2,161
-11% -$268K 0.1% 223
2024
Q1 		$2.37M Buy
18,828
+1,092
+6% +$125K 0.11% 221
2023
Q4 		$1.87M Sell
17,736
-1,084
-6% -$118K 0.09% 244
2023
Q3 		$1.99M Buy
18,820
+399
+2% +$46.2K 0.1% 215
2023
Q2 		$2.19M Buy
18,421
+1,854
+11% +$192K 0.11% 201
2023
Q1 		$1.54M Buy
16,567
+751
+5% +$65.9K 0.09% 237
2022
Q4 		$1.29M Buy
15,816
+2
+0% +$152 0.08% 231
2022
Q3 		$965K Sell
15,814
-11,523
-42% -$844K 0.07% 259
2022
Q2 		$1.94M Buy
27,337
+562
+2% +$41.1K 0.1% 216
2022
Q1 		$2.21M Sell
26,775
-394
-1% -$31.9K 0.1% 212
2021
Q4 		$2.37M Buy
27,169
+389
+1% +$36.5K 0.09% 226
2021
Q3 		$2.4M Buy
26,780
+5,097
+24% +$450K 0.09% 218
2021
Q2 		$1.77M Sell
21,683
-7,533
-26% -$590K 0.07% 258
2021
Q1 		$2.21M Sell
29,216
-3,341
-10% -$216K 0.06% 275
2020
Q4 		$2.02M Buy
32,557
+13,777
+73% +$820K 0.08% 234
2020
Q3 		$1.12M Sell
18,780
-1,492
-7% -$84.8K 0.06% 269
2020
Q2 		$1.1M Sell
20,272
-404
-2% -$21.4K 0.06% 271
2020
Q1 		$1.03M Sell
20,676
-436
-2% -$22.5K 0.07% 252
2019
Q4 		$1.13M Buy
21,112
+337
+2% +$18.6K 0.06% 279
2019
Q3 		$1.12M Buy
20,775
+1,690
+9% +$93.4K 0.07% 252
2019
Q2 		$1.09M Sell
19,085
-1,643
-8% -$88.9K 0.07% 260
2019
Q1 		$1.11M Buy
20,728
+292
+1% +$14.9K 0.07% 257
2018
Q4 		$913K Sell
20,436
-1,901
-9% -$91.1K 0.07% 262
2018
Q3 		$1.15M Sell
22,337
-2,723
-11% -$132K 0.08% 240
2018
Q2 		$1.1M Sell
25,060
-1,298
-5% -$59.8K 0.09% 207
2018
Q1 		$1.21M Buy
26,358
+1,678
+7% +$83.4K 0.11% 185
2017
Q4 		$1.17M Buy
24,680
+3,981
+19% +$195K 0.1% 185
2017
Q3 		$1M Sell
20,699
-10,615
-34% -$528K 0.1% 200
2017
Q2 		$1.57M Buy
31,314
+295
+1% +$13.4K 0.16% 139
2017
Q1 		$1.38M Buy
31,019
+13,537
+77% +$564K 0.14% 140
2016
Q4 		$672K Sell
17,482
-783
-4% -$30.6K 0.09% 207
2016
Q3 		$717K Buy
18,265
+178
+1% +$7.25K 0.1% 203
2016
Q2 		$739K Sell
18,087
-1,315
-7% -$52.5K 0.11% 182
2016
Q1 		$798K Buy
+19,402
New +$718K 0.12% 171

Other funds holding ORCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geneos Wealth Management's ORCL Position: Q1 2026 in Review

Geneos Wealth Management reduced its Oracle (ORCL) stake by 0.52% in Q1 2026, selling an estimated $19K and leaving 22,197 shares worth $3.27M. The position accounts for 0.08% of the portfolio, ranked #278.

Geneos Wealth Management first reported a position in ORCL in Q1 2016 and has held it in 41 quarters since. The position peaked at $7.23M in Q1 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Geneos Wealth Management held 22,197 shares of Oracle worth $3.27M as of Q1 2026.
  • Geneos Wealth Management sold 117 Oracle shares in Q1 2026, an estimated $19K.
  • Oracle made up 0.08% of Geneos Wealth Management's portfolio in Q1 2026, its #278 holding.
  • Geneos Wealth Management first reported a position in Oracle in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Oracle position peaked at $7.23M in Q1 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.